Publicaciones en las que colabora con Antoni Torres Martí (37)

2024

  1. Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia

    Scientific reports, Vol. 14, Núm. 1, pp. 12726

  2. Cost-Sensitive Ordinal Classification Methods to Predict SARS-CoV-2 Pneumonia Severity

    IEEE Journal of Biomedical and Health Informatics, Vol. 28, Núm. 5, pp. 2613-2623

2023

  1. Impact of outdoor air pollution on severity and mortality in COVID-19 pneumonia

    Science of the Total Environment, Vol. 894

  2. Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?

    Frontiers in Medicine, Vol. 10

  3. Validation of IDSA/ATS Guidelines for ICU Admission in Adults Over 80 Years Old With Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 59, Núm. 1, pp. 19-26

2022

  1. COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences

    Infection, Vol. 50, Núm. 1, pp. 179-189

  2. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria

    Chest, Vol. 162, Núm. 4, pp. 768-781

  3. Estimating the risk of bacteraemia in hospitalised patients with pneumococcal pneumonia

    Journal of Infection, Vol. 85, Núm. 6, pp. 644-651

2020

  1. Early and Late Cardiovascular Events in Patients Hospitalized for Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 56, Núm. 9, pp. 551-558

2018

  1. Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis

    Respiration, Vol. 96, Núm. 5, pp. 406-416

2016

  1. Age-related risk factors for bacterial aetiology in community-acquired pneumonia

    Respirology, Vol. 21, Núm. 8, pp. 1472-1479

  2. Pneumonia presenting with organ dysfunctions: Causative microorganisms, host factors and outcome

    Journal of Infection, Vol. 73, Núm. 5, pp. 419-426

  3. Predictors of severe sepsis among patients hospitalized for community-acquired pneumonia

    PLoS ONE, Vol. 11, Núm. 1

2015

  1. Sensitivity, specificity, and positivity predictors of the pneumococcal urinary antigen test in community-acquired pneumonia

    Annals of the American Thoracic Society, Vol. 12, Núm. 10, pp. 1482-1489

2014

  1. Tobacco smoking increases the risk for death from pneumococcal pneumonia

    Chest, Vol. 146, Núm. 4, pp. 1029-1037

2013

  1. Microbial aetiology of healthcare associated pneumonia in Spain: A prospective, multicentre, case-control study

    Thorax, Vol. 68, Núm. 11, pp. 1007-1014

2012

  1. Compliance with guidelines-recommended processes in pneumonia: Impact of health status and initial signs

    PLoS ONE, Vol. 7, Núm. 5

  2. Initial management of pneumonia and sepsis: Factors associated with improved outcome

    European Respiratory Journal, Vol. 39, Núm. 1, pp. 156-162

2010

  1. Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia

    Journal of Infection, Vol. 60, Núm. 2, pp. 106-113

2009

  1. Development of a prognostic index for 90-day mortality in patients discharged after admission to hospital for community-acquired pneumonia

    Thorax, Vol. 64, Núm. 6, pp. 496-501